Journal Watch · Frontiers in Immunology · 2026
Traditional Chinese medicine in sepsis-associated PICS: potential immunometabolic mechanisms and translational perspectives.
Rather than providing definitive therapeutic recommendations, this review critically synthesizes the currently available evidence, identifies important knowledge gaps, and proposes a conceptual framework to guide future mechanistic and translational studies in post-sepsis recovery.
TL;DR
Rather than providing definitive therapeutic recommendations, this review critically synthesizes the currently available evidence, identifies important knowledge gaps, and proposes a conceptual framework to guide future mechanistic and translational studies in post-sepsis recovery.
Key findings
- These factors constrain the interpretation and generalizability of current findings.
- Accordingly, the potential role of TCM in PICS should be interpreted with caution.
- Rather than providing definitive therapeutic recommendations, this review critically synthesizes the currently available evidence, identifies important knowledge gaps, and proposes a conceptual framework to guide future mechanistic and translational studies in post-sepsis recovery.
What they did
Randomized clinical studies have reported potential benefits of several Chinese herbal injections in patients with sepsis, particularly Xuebijing injection, which has been associated with improvements in short-term clinical outcomes and inflammatory markers. Experimental studies further suggest that bioactive compounds contained in herbal formulations may influence multiple biological processes relevant to immune regulation and metabolic homeostasis. However, most available evidence has been derived from studies conducted during the acute phase of sepsis rather than the prolonged recovery phase in which PICS develops. In addition, the absence of a standardized diagnostic definition for PICS, together with variability in biomarker thresholds, diagnostic timing, and outcome measures across studies, limits comparability and may introduce heterogeneity in patient selection.
Full abstract (original)
Background: Persistent inflammation, immunosuppression, and catabolism syndrome (PICS) has emerged as an important contributor to long-term morbidity among survivors of sepsis. This syndrome is characterized by sustained immune dysregulation, metabolic disturbances, and progressive skeletal muscle wasting, reflecting a failure of coordinated recovery following severe infection. Although advances in critical care have improved early survival, effective strategies targeting the complex immunometabolic alterations underlying PICS remain limited. Traditional Chinese medicine (TCM) has increasingly been investigated as an adjunctive approach in critical care.
What they did: Randomized clinical studies have reported potential benefits of several Chinese herbal injections in patients with sepsis, particularly Xuebijing injection, which has been associated with improvements in short-term clinical outcomes and inflammatory markers. Experimental studies further suggest that bioactive compounds contained in herbal formulations may influence multiple biological processes relevant to immune regulation and metabolic homeostasis. However, most available evidence has been derived from studies conducted during the acute phase of sepsis rather than the prolonged recovery phase in which PICS develops. In addition, the absence of a standardized diagnostic definition for PICS, together with variability in biomarker thresholds, diagnostic timing, and outcome measures across studies, limits comparability and may introduce heterogeneity in patient selection.
Results & conclusions: These factors constrain the interpretation and generalizability of current findings. Accordingly, the potential role of TCM in PICS should be interpreted with caution. Rather than providing definitive therapeutic recommendations, this review critically synthesizes the currently available evidence, identifies important knowledge gaps, and proposes a conceptual framework to guide future mechanistic and translational studies in post-sepsis recovery.
Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1827446 · PubMed 42676804.
Why it matters for pharma & biotech
- Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
- Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Frontiers in Immunology study find?
Rather than providing definitive therapeutic recommendations, this review critically synthesizes the currently available evidence, identifies important knowledge gaps, and proposes a conceptual framework to guide future mechanistic and translational studies in post-sepsis recovery.
What type of study is this?
It is a randomised / controlled clinical trial, published in Frontiers in Immunology in 2026. Randomized clinical studies have reported potential benefits of several Chinese herbal injections in patients with sepsis, particularly Xuebijing injection, which has been associated with improvements in short-term clinical outcomes and inflammatory markers.
Where can I read the original paper?
The original is at the publisher via DOI 10.3389/fimmu.2026.1827446. PubMed ID: 42676804. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/traditional-chinese-medicine-in-sepsis-associated-pics-potential-immunom-827446/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides